Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Effect of Mirtazapine on Anxiety in Parkinson's Disease Patients; a Randomized Double-blinded Placebo-controlled Clinical Trial

NCT06530290 is registered in ClinicalTrials.gov with Leila Dargahi. PharmD PhD as lead sponsor.

NCT NCT06530290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06530290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Effect of Mirtazapine on Anxiety in Parkinson's Disease Patients; a Randomized Double-blinded Placebo-controlled Clinical Trial
Lead sponsor
Leila Dargahi. PharmD PhD
Phase
Phase 2
Overall status
Unknown status
Start date
June 1, 2022
Completion date
June 30, 2026
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, parkinson disease